IFNB1 and autoimmune disease: Compared to IFNA and IFNB, IFNT displays similar immunomodulatoryfunctions but low cytotoxicity even at higher dose, thus can provide a new option to treat obesity-induced insulin resistance and autoimmune disorders [31], [33].